Calidi Biotherapeutics Inc. (CLDI) — Working Capital to Net Assets Ratio
Calidi Biotherapeutics Inc. (CLDI) has a Working Capital to Net Assets ratio of 61.7% as of December 2025. Working capital of $2.32 Million (current assets of $6.26 Million minus current liabilities of $3.94 Million) is measured against net assets of $3.76 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See CLDI defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Calidi Biotherapeutics Inc. Working Capital to Net Assets (2020–2025)
This chart shows how Calidi Biotherapeutics Inc.'s Working Capital to Net Assets ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 61.7%, reflecting working capital of $2.32 Million against net assets of $3.76 Million USD. For the complete balance sheet picture, see CLDI current and non-current assets.
Annual Working Capital to Net Assets for Calidi Biotherapeutics Inc. (2020–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Calidi Biotherapeutics Inc. from 2020 to 2025, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Calidi Biotherapeutics Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 61.7% | $2.32 Million | $3.76 Million | $6.26 Million | $3.94 Million | ▲ +24.6 pp |
| 2024 | 37.1% | $731.00K | $1.97 Million | $10.23 Million | $9.50 Million | ▼ -34.9 pp |
| 2023 | 72.0% | $-5.93 Million | $-8.23 Million | $4.30 Million | $10.23 Million | ▼ -11.7 pp |
| 2022 | 83.7% | $-42.20 Million | $-50.44 Million | $786.00K | $42.99 Million | ▼ -19.0 pp |
| 2021 | 102.7% | $-23.22 Million | $-22.61 Million | $2.74 Million | $25.96 Million | ▲ +65.4 pp |
| 2020 | 37.3% | $-8.38 Million | $-22.48 Million | $513.00K | $8.89 Million | — |